Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Probiotic484 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A00010 | 35255811 | BMC Gastroenterol | The effect of daily consumption of probiotic yogurt on liver enzymes, steatosis and fibrosis in patients with nonalcoholic fatty liver disease (NAFLD): study protocol for a randomized clinical trial. | 2022 | Details |
| A00094 | 35222044 | Front Pharmacol | Antibiotic Disruption of the Gut Microbiota Enhances the Murine Hepatic Dysfunction Associated With a High-Salt Diet. | 2022 | Details |
| A00113 | 35216439 | Int J Mol Sci | Heat-Inactivated Akkermansia muciniphila Improves Gut Permeability but Does Not Prevent Development of Non-Alcoholic Steatohepatitis in Diet-Induced Obese Ldlr-/-.Leiden Mice. | 2022 | Details |
| A00181 | 35195774 | Arch Microbiol | A review on the effect of gut microbiota on metabolic diseases. | 2022 | Details |
| A00229 | 35174500 | J Sci Food Agric | Identification of a novel probiotic and its protective effects on NAFLD via modulating gut microbial community. | 2022 | Details |
| A00521 | 35053962 | Foods | Limosilactobacillus fermentum MG4295 Improves Hyperglycemia in High-Fat Diet-Induced Mice. | 2022 | Details |
| A00526 | 35053205 | Biomolecules | Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives. | 2021 | Details |
| A00533 | 35052765 | Biomedicines | Bifidobacterium bifidum Shows More Diversified Ways of Relieving Non-Alcoholic Fatty Liver Compared with Bifidobacterium adolescentis. | 2021 | Details |
| A00706 | 34994824 | Naunyn Schmiedebergs Arch Pharmacol | The crucial role of oxidative stress in non-alcoholic fatty liver disease-induced male reproductive toxicity: the ameliorative effects of Iranian indigenous probiotics. | 2022 | Details |
| A00758 | 34978141 | Obes Rev | Human microbiome and metabolic health: An overview of systematic reviews. | 2022 | Details |
| A00794 | 34965016 | Clin Transl Med | Lactobacillus lactis and Pediococcus pentosaceus-driven reprogramming of gut microbiome and metabolome ameliorates the progression of non-alcoholic fatty liver disease. | 2021 | Details |
| A00808 | 34959747 | Nutrients | High-Fructose, High-Fat Diet Alters Muscle Composition and Fuel Utilization in a Juvenile Iberian Pig Model of Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A00822 | 34957088 | Front Cell Dev Biol | Molecular Immune Mechanism of Intestinal Microbiota and Their Metabolites in the Occurrence and Development of Liver Cancer. | 2021 | Details |
| A00851 | 34948020 | Int J Mol Sci | The New Therapeutic Approaches in the Treatment of Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A00854 | 34945677 | Foods | Lactobacillus plantarum MA2 Ameliorates Methionine and Choline-Deficient Diet Induced Non-Alcoholic Fatty Liver Disease in Rats by Improving the Intestinal Microecology and Mucosal Barrier. | 2021 | Details |
| A00956 | 34919684 | J Nutr | A Specifically Tailored Multistrain Probiotic and Micronutrient Mixture Affects Nonalcoholic Fatty Liver Disease-Related Markers in Patients with Obesity after Mini Gastric Bypass Surgery. | 2022 | Details |
| A01074 | 34877910 | Expert Rev Gastroenterol Hepatol | Effects of probiotics on nonalcoholic fatty liver disease: a systematic review and meta-analysis. | 2021 | Details |
| A01191 | 34835410 | Microorganisms | Polyclonal Aptamers for Specific Fluorescence Labeling and Quantification of the Health Relevant Human Gut Bacterium Parabacteroides distasonis. | 2021 | Details |
| A01352 | 34778099 | Front Cell Infect Microbiol | Gut Microbiota, Glucose, Lipid, and Water-Electrolyte Metabolism in Children With Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01357 | 34776827 | Food Nutr Res | Weissella cibaria MG5285 and Lactobacillus reuteri MG5149 attenuated fat accumulation in adipose and hepatic steatosis in high-fat diet-induced C57BL/6J obese mice. | 2021 | Details |
| A01366 | 34773939 | Clin Exp Pediatr | Effects of probiotics combined with dietary and lifestyle modification on clinical, biochemical, and radiological parameters in obese children with NASH/NAFLD: a randomized clinical trial. | 2021 | Details |
| A01403 | 34758930 | Arch Pediatr | The role of nutrition in non-alcoholic fatty liver disease treatment in obese children. | 2021 | Details |
| A01446 | 34742934 | Arch Biochem Biophys | The probiotic effects of AB23A on high-fat-diet-induced non-alcoholic fatty liver disease in mice may be associated with suppressing the serum levels of lipopolysaccharides and branched-chain amino acids. | 2021 | Details |
| A01474 | 34734433 | J Gastroenterol Hepatol | New perspective on fecal microbiota transplantation in liver diseases. | 2022 | Details |
| A01475 | 34734369 | J Gastrointest Surg | The Role of Gut-Derived Lipopolysaccharides and the Intestinal Barrier in Fatty Liver Diseases. | 2021 | Details |
| A01816 | 34606532 | Food Funct | Beneficial impacts of fermented celery (Apium graveolens L.) juice on obesity prevention and gut microbiota modulation in high-fat diet fed mice. | 2021 | Details |
| A01838 | 34598315 | Immun Inflamm Dis | Multidirectional facets of obesity management in the metabolic syndrome population after liver transplantation. | 2021 | Details |
| A01868 | 34579068 | Nutrients | The Effect of Probiotics (MCP® BCMC® Strains) on Hepatic Steatosis, Small Intestinal Mucosal Immune Function, and Intestinal Barrier in Patients with Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A01921 | 34561722 | Eur J Nutr | Effects of β-glucan, probiotics, and synbiotics on obesity-associated colitis and hepatic manifestations in C57BL/6J mice. | 2021 | Details |
| A02082 | 34511051 | Benef Microbes | Probiotic and prebiotic interventions for non-alcoholic fatty liver disease: a systematic review and network meta-analysis. | 2021 | Details |
| A02148 | 34486133 | J Food Biochem | Regulatory mechanisms of energy metabolism and inflammation in oleic acid-treated HepG2 cells from Lactobacillus acidophilus NX2-6 extract. | 2021 | Details |
| A02213 | 34458376 | J Immunol Res | Probiotics Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats via Gut Microbiota/FXR/FGF15 Signaling Pathway. | 2021 | Details |
| A02267 | 34441497 | Foods | Probiotics and Prebiotics as a Strategy for Non-Alcoholic Fatty Liver Disease, a Narrative Review. | 2021 | Details |
| A02307 | 34426178 | J Integr Med | Hepatic protective effects of Shenling Baizhu powder, a herbal compound, against inflammatory damage via TLR4/NLRP3 signalling pathway in rats with nonalcoholic fatty liver disease. | 2021 | Details |
| A02374 | 34399486 | Food Res Int | Protective and ameliorating effects of probiotics against diet-induced obesity: A review. | 2021 | Details |
| A02375 | 34399465 | Food Res Int | Regulatory effects of Lactobacillus fermented black barley on intestinal microbiota of NAFLD rats. | 2021 | Details |
| A02389 | 34392687 | J Agric Food Chem | Understanding Choline Bioavailability and Utilization: First Step Toward Personalizing Choline Nutrition. | 2021 | Details |
| A02469 | 34360923 | Int J Mol Sci | The Role of Leaky Gut in Nonalcoholic Fatty Liver Disease: A Novel Therapeutic Target. | 2021 | Details |
| A02471 | 34360773 | Int J Mol Sci | Effect of Microbiome on Non-Alcoholic Fatty Liver Disease and the Role of Probiotics, Prebiotics, and Biogenics. | 2021 | Details |
| A02532 | 34339764 | J Hepatol | Prevention of NAFLD-associated HCC: Role of lifestyle and chemoprevention. | 2021 | Details |
| A02552 | 34330514 | Clin Nutr ESPEN | Contribution of gut microbiota to nonalcoholic fatty liver disease: Pathways of mechanisms. | 2021 | Details |
| A02694 | 34280304 | Cochrane Database Syst Rev | Nutritional supplementation for nonalcohol-related fatty liver disease: a network meta-analysis. | 2021 | Details |
| A02733 | 34267042 | Curr Opin Infect Dis | The impact of alteration in gut microbiome in the pathogenesis of nonalcoholic fatty liver disease. | 2021 | Details |
| A02769 | 34250000 | Front Nutr | Role of the Gut Microbiota in Regulating Non-alcoholic Fatty Liver Disease in Children and Adolescents. | 2021 | Details |
| A02865 | 34212214 | Inflamm Res | Mechanistic and physiological approaches of fecal microbiota transplantation in the management of NAFLD. | 2021 | Details |
| A02892 | 34204274 | Int J Mol Sci | Nonalcoholic Fatty Liver Disease (NAFLD) as Model of Gut-Liver Axis Interaction: From Pathophysiology to Potential Target of Treatment for Personalized Therapy. | 2021 | Details |
| A02977 | 34176456 | Curr Pharm Des | Gut Microbiota as an Emerging Therapeutic Avenue for the Treatment of Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A03114 | 34125646 | Gut Microbes | Desulfovibrio vulgaris, a potent acetic acid-producing bacterium, attenuates nonalcoholic fatty liver disease in mice. | 2021 | Details |
| A03206 | 34090052 | Biomed Pharmacother | Probiotic-prebiotic-synbiotic modulation of (YAP1, LATS1 and NF2 mRNAs/miR-1205/lncRNA SRD5A3-AS1) panel in NASH animal model. | 2021 | Details |
| A03420 | 34006994 | Eur J Clin Nutr | Non-alcoholic fatty liver disease in obese children and adolescents: a role for nutrition? | 2021 | Details |
| A03506 | 33978391 | Minerva Gastroenterol (Torino) | Probiotics and gut health. | 2021 | Details |
| A03556 | 33957682 | Semin Liver Dis | New Developments in Microbiome in Alcohol-Associated and Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A03579 | 33946843 | Microorganisms | Gut Microbiota and NAFLD: Pathogenetic Mechanisms, Microbiota Signatures, and Therapeutic Interventions. | 2021 | Details |
| A03731 | 33887125 | United European Gastroenterol J | Gut fermentation syndrome: A systematic review of case reports. | 2021 | Details |
| A03903 | 33824675 | Evid Based Complement Alternat Med | Jian-Gan-Xiao-Zhi Decoction Alleviates Inflammatory Response in Nonalcoholic Fatty Liver Disease Model Rats through Modulating Gut Microbiota. | 2021 | Details |
| A03962 | 33807605 | Int J Mol Sci | Mechanisms by Which Probiotic Bacteria Attenuate the Risk of Hepatocellular Carcinoma. | 2021 | Details |
| A03999 | 33794784 | BMC Gastroenterol | A randomised placebo controlled trial of VSL#3® probiotic on biomarkers of cardiovascular risk and liver injury in non-alcoholic fatty liver disease. | 2021 | Details |
| A04080 | 33767591 | Int J Biol Sci | Understanding the Effects of Gut Microbiota Dysbiosis on Nonalcoholic Fatty Liver Disease and the Possible Probiotics Role: Recent Updates. | 2021 | Details |
| A04200 | 33718398 | Front Med (Lausanne) | Oxidative Stress in Non-alcoholic Fatty Liver Disease. An Updated Mini Review. | 2021 | Details |
| A04203 | 33716447 | World J Gastroenterol | G protein-coupled receptors as potential targets for nonalcoholic fatty liver disease treatment. | 2021 | Details |
| A04284 | 33678110 | Gut Microbes | Akkermansia muciniphila and environmental enrichment reverse cognitive impairment associated with high-fat high-cholesterol consumption in rats. | 2022 | Details |
| A04285 | 33678036 | Hum Exp Toxicol | Early intervention with probiotics and metformin alleviates liver injury in NAFLD rats via targeting gut microbiota dysbiosis and p-AKT/mTOR/LC-3II pathways. | 2021 | Details |
| A04440 | 33615993 | Gut Microbes | Modulation of the PI3K/Akt/mTOR signaling pathway by probiotics as a fruitful target for orchestrating the immune response. | 2022 | Details |
| A04600 | 33567710 | Int J Environ Res Public Health | Nutritional Approach Targeting Gut Microbiota in NAFLD-To Date. | 2021 | Details |
| A04611 | 33564651 | Clin Nutr Res | Probiotic Yogurt Fortified with Vitamin D Can Improve Glycemic Status in Non-Alcoholic Fatty Liver Disease Patients: a Randomized Clinical Trial. | 2021 | Details |
| A04617 | 33561650 | Biomed Pharmacother | The intestinal microbiota as a therapeutic target in the treatment of NAFLD and ALD. | 2021 | Details |
| A04632 | 33557031 | Life (Basel) | Adiposity in Depression or Depression in Adiposity? The Role of Immune-Inflammatory-Microbial Overlap. | 2021 | Details |
| A04649 | 33552218 | Evid Based Complement Alternat Med | Probiotics as a Complementary Therapy for Management of Obesity: A Systematic Review. | 2021 | Details |
| A04668 | 33546191 | Biomedicines | Insights into the Impact of Microbiota in the Treatment of NAFLD/NASH and Its Potential as a Biomarker for Prognosis and Diagnosis. | 2021 | Details |
| A04793 | 33505139 | World J Gastroenterol | Gut microbiota mediated molecular events and therapy in liver diseases. | 2020 | Details |
| A04947 | 33440736 | Nutrients | Bifidobacterium breve CNCM I-4035, Lactobacillus paracasei CNCM I-4034 and Lactobacillus rhamnosus CNCM I-4036 Modulate Macrophage Gene Expression and Ameliorate Damage Markers in the Liver of Zucker-Lepr fa/fa Rats. | 2021 | Details |
| A05018 | 33409398 | Transl Gastroenterol Hepatol | Gut microbiome changes in Nonalcoholic fatty liver disease & alcoholic liver disease. | 2021 | Details |
| A05053 | 33392241 | Front Nutr | The Effects of Foods on Blood Lipids in Non-alcoholic Fatty Liver Disease (NAFLD)-A Systematic Review and Meta-Analysis. | 2020 | Details |
| A05088 | 33382431 | J Nutr | Polylactose Exhibits Prebiotic Activity and Reduces Adiposity and Nonalcoholic Fatty Liver Disease in Rats Fed a High-Fat Diet. | 2021 | Details |
| A05227 | 33331485 | Arq Gastroenterol | GUT MICROBIOTA, PREBIOTICS, PROBIOTICS, AND SYNBIOTICS IN GASTROINTESTINAL AND LIVER DISEASES: PROCEEDINGS OF A JOINT MEETING OF THE BRAZILIAN SOCIETY OF HEPATOLOGY (SBH), BRAZILIAN NUCLEUS FOR THE STUDY OF HELICOBACTER PYLORI AND MICROBIOTA (NBEHPM), AND BRAZILIAN FEDERATION OF GASTROENTEROLOGY (FBG). | 2021 | Details |
| A05273 | 33317254 | Clin Mol Hepatol | Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis. | 2020 | Details |
| A05331 | 33299871 | Biomed Res Int | Protective Role of Probiotic Supplements in Hepatic Steatosis: A Rat Model Study. | 2020 | Details |
| A05366 | 33281535 | Food Nutr Res | Bile salt hydrolase-overexpressing Lactobacillus strains can improve hepatic lipid accumulation in vitro in an NAFLD cell model. | 2020 | Details |
| A05654 | 33171747 | Int J Mol Sci | The Gut Barrier, Intestinal Microbiota, and Liver Disease: Molecular Mechanisms and Strategies to Manage. | 2020 | Details |
| A05757 | 33131411 | Gut Microbes | Lactobacillus lactis CKDB001 ameliorate progression of nonalcoholic fatty liver disease through of gut microbiome: addendum. | 2020 | Details |
| A05786 | 33117316 | Front Microbiol | Microbial Metabolites: Critical Regulators in NAFLD. | 2020 | Details |
| A05981 | 33053631 | Nutrients | Microbiota, Fiber, and NAFLD: Is There Any Connection? | 2020 | Details |
| A05985 | 33050862 | Curr Pharm Biotechnol | Engineered Probiotic and Prebiotic Nutraceutical Supplementations in Combating Non-communicable Disorders: A Review. | 2022 | Details |
| A06020 | 33037249 | Sci Rep | Pathophysiology of high fat diet induced obesity: impact of probiotic banana juice on obesity associated complications and hepatosteatosis. | 2020 | Details |
| A06116 | 32999906 | GE Port J Gastroenterol | Gastrointestinal Microbiome - What We Need to Know in Clinical Practice. | 2020 | Details |
| A06164 | 32981386 | Expert Rev Clin Pharmacol | The pharmacological treatment of nonalcoholic fatty liver disease in children. | 2020 | Details |
| A06273 | 32945305 | Food Funct | Lactobacillus fermentum CQPC06 in naturally fermented pickles prevents non-alcoholic fatty liver disease by stabilizing the gut-liver axis in mice. | 2020 | Details |
| A06327 | 32927776 | Nutrients | New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative Stress. | 2020 | Details |
| A06423 | 32885440 | J Food Sci | Effects of probiotic and prebiotic supplementation on metabolic parameters, liver aminotransferases, and systemic inflammation in nonalcoholic fatty liver disease: A randomized clinical trial. | 2020 | Details |
| A06455 | 32876312 | Rev Paul Pediatr | THE THERAPEUTIC IMPACT OF PROBIOTICS ON NONALCOHOLIC FATTY LIVER DISEASE IN PEDIATRICS: A SYSTEMATIC REVIEW. | 2020 | Details |
| A06471 | 32867260 | Medicina (Kaunas) | Probiotics: Versatile Bioactive Components in Promoting Human Health. | 2020 | Details |
| A06474 | 32865911 | Crit Rev Oncog | Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease Progression. | 2020 | Details |
| A06488 | 32859329 | Clin Nutr ESPEN | The effects of Bacillus coagulans supplementation in patients with non-alcoholic fatty liver disease: A randomized, placebo-controlled, clinical trial. | 2020 | Details |
| A06558 | 32825440 | Int J Mol Sci | Microbiota-Associated Therapy for Non-Alcoholic Steatohepatitis-Induced Liver Cancer: A Review. | 2020 | Details |
| A06565 | 32824277 | Int J Mol Sci | Lactobacillus Strains Alleviated Hyperlipidemia and Liver Steatosis in Aging Rats via Activation of AMPK. | 2020 | Details |
| A06573 | 32822325 | Orv Hetil | The potential role of organic and conventional yoghurt consumption in the treatment of non-alcoholic fatty liver disease | 2020 | Details |
| A06661 | 32791115 | Cell Host Microbe | Microbiota and Fatty Liver Disease-the Known, the Unknown, and the Future. | 2020 | Details |
| A06688 | 32780531 | Mol Nutr Food Res | Lactobacillus rhamnosus GG and Oat Beta-Glucan Regulated Fatty Acid Profiles along the Gut-Liver-Brain Axis of Mice Fed with High Fat Diet and Demonstrated Antioxidant and Anti-Inflammatory Potentials. | 2020 | Details |
| A06722 | 32769877 | Medicine (Baltimore) | Protective effect of probiotics in patients with non-alcoholic fatty liver disease. | 2020 | Details |
| A06740 | 32764281 | Nutrients | The Relationship between Choline Bioavailability from Diet, Intestinal Microbiota Composition, and Its Modulation of Human Diseases. | 2020 | Details |